PrintAlert
Richmond Minerals Inc. (TSXV:RMD)
Intraday Stock Chart
Today : Monday 18 March 2013
TORONTO, March 18, 2013 /CNW/ - (RMD: TSXV) Richmond Minerals ("Richmond" or the "Company") is pleased to announce that a new purchase agreement has been reached with ARC Corporation ("ARC") whereby the Company will sell its 100% interest in the Lac Colombet Property to ARC for payment of Cdn $5,000 and the issuance of 2,000,000 common shares of ARC to Richmond. ARC shall have the right to terminate this purchase agreement if the CNSX Stock Exchange fails to accept the proposed arrangement for the Lac Colombet Property as the qualifying transaction for the ARC's listing on the CNSX Stock Exchange. If such an event occurs, the purchase agreement shall be terminated and Richmond will return the common shares of ARC, and ARC agrees to forfeit the deposit of $5,000. Richmond shall also have the right to terminate this purchase agreement if ARC fails to list its common shares on a recognized stock exchange within 6 months from the date of signing of this purchase agreement. If such an event occurs, this purchase agreement shall be terminated and the Richmond will return the common shares of ARC, and ARC agrees to forfeit the deposit of $5,000.
Furthermore, the TSX Venture Exchange (the "Exchange") has accepted for filing Surrey Capital Corporation's ("Surrey") Qualifying Transaction described in Surrey's Filing Statement dated January 28, 2013 and its press release dated March 1, 2013. As a result, at the opening of March 15, 2013 Exchange trading session, Surrey was no longer considered a Capital Pool Company. The Qualifying Transaction includes the following:
Surrey entered into an Option Agreement (the "Agreement") dated December 31, 2012 with Richmond and Mag Copper Limited ("Mag" and, together with Richmond, the "Vendors"). The Agreement will permit Surrey to earn a 50% interest in the Halle Township, Quebec Property, upon the payment of $20,000 and the issuance of 200,000 common shares of Surrey to the Vendors upon release of the Final Exchange Bulletin (the "Bulletin") and the issuance of an additional 400,000 common shares of the Corporation prior to the first anniversary of the release of the Bulletin, as well as the expenditure of a minimum of $200,000 in exploration costs within the first year following the release of the Bulletin.
Finally, litigation is underway pertaining to the Certificate of Pending Proceeding attached to the Company's Swayze Township Property claims in Northern Ontario. The certificates date back to 1990 and the plaintiff in this action seeks title to the Swayze Property and potential financial compensation from Richmond. Richmond is defending itself and expects a resolution in this matter later this year. Additionally Richmond recently staked 47 claim units that are contiguous with the western claim boundary of the Swayze claims (the "Raney Property"). Numerous historical gold-bearing mineralized zones have been identified on the claims immediately to the east and west of the Raney Property. An east-west trending airborne EM and magnetic anomaly was identified on the Raney Property in the mid 1980's and little follow-up exploration work on this target has been recorded since that time.
Warren Hawkins, P.Eng, a "Qualified Person", within the meaning of National Instrument 43-101 - Standards of Disclosure for Mineral Projects, has reviewed and approved the scientific and technical information contained in this news release. Mr. Hawkins is not considered to be "independent" of the Company (as defined in National Instrument 43-101), as he currently holds securities of Richmond.
Cautionary Note Regarding Forward-Looking Statements: Certain disclosure in this release constitute forward-looking statements. In making the forward-looking statements in this release, the Company has applied certain factors and assumptions that are based on the Company's current beliefs as well as assumptions made by and information currently available to the Company. Although the Company considers these assumptions to be reasonable based on information currently available to it, they may prove to be incorrect, and the forward-looking statements in this release are subject to numerous risks, uncertainties and other factors that may cause future results to differ materially from those expressed or implied in such forward-looking statements. Such risk factors include, among others, that the litigation will be resolved. Readers are cautioned not to place undue reliance on forward-looking statements. The Company does not intend, and expressly disclaims any intention or obligation to, update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by law.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.
On Behalf of Richmond Minerals,
{signed}
Franz Kozich
President
SOURCE Richmond Minerals Inc.
Copyright 2013 Canada NewsWire
-------------------------------------------------------------------
All posts are strictly my opinion and are not buy or sell recommendations.
Recent RMD News
- ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2024 • GlobeNewswire Inc. • 04/25/2024 08:05:00 PM
- ResMed to Report Third Quarter Fiscal 2024 Earnings on April 25, 2024 • GlobeNewswire Inc. • 04/04/2024 08:05:00 PM
- ResMed's 2024 Global Sleep Survey Uncovers a World in Sleep Crisis • GlobeNewswire Inc. • 03/15/2024 07:05:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 01:46:43 AM
- Introducing the AirFit F40: Experience Unprecedented Freedom with the Comfort and Optimized Seal Performance of ResMed’s Smallest Full-Face CPAP Mask • GlobeNewswire Inc. • 03/06/2024 02:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 12:11:51 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2024 10:55:11 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/01/2024 10:08:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 11:40:35 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/23/2024 02:41:49 AM
- ResMed’s New AirCurve™ 11 Bilevel Devices Enable Healthcare Providers to Make Informed Decisions about Care, Deliver Personalized Support, and Drive Positive Therapy Outcomes for Patients with Sleep Apnea • GlobeNewswire Inc. • 02/12/2024 09:16:33 PM
- MatrixCare Earns Three 2024 Best in KLAS Awards • GlobeNewswire Inc. • 02/07/2024 01:05:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/06/2024 04:21:45 PM
- Philips Shares Drop 6% as US Sales Halted Following Agreement on Faulty Sleep Apnea Devices, and more Wall Street Highlights • IH Market News • 01/29/2024 11:09:38 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/25/2024 06:48:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/24/2024 09:06:01 PM
- ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2024 • GlobeNewswire Inc. • 01/24/2024 09:05:00 PM
- ResMed to Report Second Quarter Fiscal 2024 Earnings on January 24, 2024 • GlobeNewswire Inc. • 01/03/2024 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 08:20:12 PM
- ResMed Announces Participation in the 42nd Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 12/27/2023 09:05:00 PM
- ResMed Notifies Customers About Updated Instructions and Labeling for Masks with Magnets Due to Potential Interference with Certain Medical Devices • GlobeNewswire Inc. • 12/20/2023 09:05:00 PM
- ResMed Secures Significant Victory in Patent Fight Against New York University • GlobeNewswire Inc. • 12/11/2023 09:05:00 PM
- Study Estimates a 23% Increase in COPD by 2050, Representing 600 Million Patients Globally • GlobeNewswire Inc. • 12/07/2023 08:34:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/30/2023 12:45:21 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM